Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Literature
1.
Kucukkelepce GE, Dinc L, Elcin M. Effects of using standardized patients on nursing students’ moral skills. Nurs Ethics. 2020;27(7):1587–602.CrossRefPubMed
2.
Altun S, Tastan S. Low-fidelity simulation vs. standardized patients in prevention and management of pressure injury education. J Tissue Viability. 2022;31(4):643–8.CrossRefPubMed
3.
Dorr DA, Adams L, Embí P. Harnessing the promise of artificial intelligence responsibly. JAMA. 2023;329(16):1347–8.CrossRefPubMed
4.
van Dis EAM, Bollen J, Zuidema W, van Rooij R, Bockting CL. ChatGPT: five priorities for research. Nature. 2023;614(7947):224–6.CrossRefPubMed
5.
Preiksaitis C, Sinsky CA, Rose C. ChatGPT is not the solution to physicians’ documentation burden. Nat Med. 2023;29(6):1296–7.CrossRefPubMed
Metadata
Title
ChatGPT: when the artificial intelligence meets standardized patients in clinical training
Authors
Xiaoni Liu
Chaoling Wu
Rui Lai
Hai Lin
Yiying Xu
Yuansheng Lin
Weilong Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2023
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-023-04314-0

Other articles of this Issue 1/2023

Journal of Translational Medicine 1/2023 Go to the issue

Research

Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer

Research

Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression

Research

The HIFIA/LINC02913/IGF1R axis promotes the cell function of adipose-derived mesenchymal stem cells under hypoxia via activating the PI3K/AKT pathway

Editorial

Cell death and senescence

Correction

Correction: Current advances in gene therapy of mitochondrial diseases

Review

SARS-CoV-2 before and after Omicron: two different viruses and two different diseases?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits